Stock screenerAll disclosures →
EDGAR →
ORKA
Conviction 100HealthcareScan · Fri, Jun 26, 2026ORKA$90.56+4.54%
ResistanceSupportVol 14Insider sell2
3
4
3
6
3
Vol MA14 1.82M
Mar 27Apr 15May 4May 20Jun 9Jun 26
Price90.56
Change+4.54%
Gap-0.47%
Rel volume3.63×
Avg volume1.63M
Avg $ vol120.84M
SMA 2069.48
SMA 5066.87
SMA 20040.45
Price vs 50+35.43%
Price vs 200+123.91%
MA stackbullish
50/200 cross—
Supertrendup · 71.97
RSI (14)75
MACD hist2.45
MACD cross—
Stoch %K / %D99 / 90
ADX (14)37
+DI / −DI39 / 10
RSI divergence—
MACD divergence—
ATR %+5.64%
ADR %6.46%
52w high90.56
52w low11.08
From 52w high+0.00%
Above 52w low+717.33%
New 52w highYes
SqueezeOff
Bollinger width61.02%
%B1.00
Donchian pos98.85%
Donchian high90.99
Donchian low53.62
AVWAP (52w high)70.13
vs AVWAP high+29.13%
AVWAP (52w low)50.48
vs AVWAP low+79.38%
OBV trendUp
Chaikin MF (20)0.21
Today vs 20d3.63×
Avg vol (14d)1.82M
Avg vol (20d)1.63M
Avg $ vol (20d)120.84M
Market cap—
RS 3m (vs SPY)+85.94%
RS 6m (vs SPY)+163.75%
RS line new highYes
Trend template8/8
Technical rank97.3
1 week+25.19%
1 month+56.16%
3 months+99.21%
6 months+185.59%
1 year+678.68%
YTD+220.34%
P/E-49.73
P/B10.77
P/S—
P/FCF-59.30
EPS-3.87
Div yield—
ROE-21.66%
ROA-20.90%
Debt/Eq—
Current23.76
EV/EBITDA-42.56
Gross margin—
Net margin—
Rev growth—
EPS growth-25.93%
Price target148.20
Target upside70.48%
Analyst ratingBuy
Institutional90.50%
Ent. value5.19B
Revenue0
Net income-31.82M
Gross profit—
Free cash flow-88.42M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out60.31M
Employees68
ListedTue, Sep 3, 2024
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeA+
Conviction100 / 100
Pattern quality—
Tech rank97.3 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance80.27
Support54.31
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in ORKA
No recent disclosed trades by Congress in ORKA. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in ORKA · 8 buys · 2 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Agarwal Arjun Senior Vice President, Finance · Common Stock · 2026-06-22 | Sell | 888 | $71K | 2026-06-22 | 2026-06-22 |
Agarwal Arjun Senior Vice President, Finance · Common Stock · 2026-06-22 | Sell | 699 | $57K | 2026-06-22 | 2026-06-22 |
Fairmount Healthcare Co-Invest III L.P. Director · Stock Option (Right to Buy) · 2026-06-02 | Grant | 9.14K | $0 | 2026-06-02 | 2026-06-03 |
Harwin Peter Evan Director · Stock Option (Right to Buy) · 2026-06-02 | Grant | 9.14K | $0 | 2026-06-02 | 2026-06-03 |
Kiselak Tomas Director · Stock Option (Right to Buy) · 2026-06-02 | Grant | 9.14K | $0 | 2026-06-02 | 2026-06-03 |
Martin Christopher Nathan Director · Stock Option (right to buy) · 2026-06-02 | Grant | 9.14K | $0 | 2026-06-02 | 2026-06-03 |
Kulkarni Samarth Director · Stock Option (right to buy) · 2026-06-02 | Grant | 9.14K | $0 | 2026-06-02 | 2026-06-03 |
Fairmount Funds Management LLC Director · Stock Option (Right to Buy) · 2026-06-02 | Grant | 9.14K | $0 | 2026-06-02 | 2026-06-03 |
BALL KRISTINE M Director · Stock Option (right to buy) · 2026-06-02 | Grant | 9.14K | $0 | 2026-06-02 | 2026-06-03 |
Fairmount Healthcare Fund II L.P. Director · Stock Option (Right to Buy) · 2026-06-02 | Grant | 9.14K | $0 | 2026-06-02 | 2026-06-03 |
SEC filings
EDGAR filings in ORKA · 3 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.